NDC 73309-303-01 - Sevelamer Carbonate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73309-303
- Requested NDC
- 73309-303-01
- Package NDCs from labels
- 73309-303-01
- Manufacturer
- Bluebay Shangdong Co.,LTD
- Effective date
- 2021-06-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Sevelamer Carbonate - Bluebay Shangdong Co.,LTD | Bluebay Shangdong Co.,LTD | 2021-06-17 | BULK INGREDIENT |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73309-303-01 | Sevelamer Carbonate | 500 g in 1 JAR | POWDER | 500 | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SEVELAMER CARBONATE | SEVELAMER CARBONATE | Strides Pharma Science Limited | c17bff97-8347-43f8-822e-1cb9736562b6 | 2025-07-09 | Warnings, Adverse reactions | 9YCX42I8IU |
| Sevelamer Carbonate | SEVELAMER CARBONATE | ATLANTIC BIOLOGICALS CORP. | 07b709fd-a2a1-4ff1-ad19-827d38e84562 | 2025-06-27 | Warnings, Adverse reactions | 9YCX42I8IU |
| Sevelamer Carbonate | SEVELAMER CARBONATE | Golden State Medical Supply, Inc. | 3779296e-35bc-5b03-e063-6294a90a0214 | 2025-06-13 | Warnings, Adverse reactions | 9YCX42I8IU |
| Sevelamer Carbonate | SEVELAMER CARBONATE | Cardinal Health 107, LLC | 61d073ec-51a4-48c7-8762-25fdd00fe6ac | 2025-06-06 | Warnings, Adverse reactions | 9YCX42I8IU |
| Sevelamer Carbonate | SEVELAMER CARBONATE | DR. REDDY'S LABORATORIES LIMITED | 0085356d-5fec-3cce-2bd3-108be70e515d | 2025-04-01 | Warnings, Adverse reactions | 9YCX42I8IU |
| Sevelamer Carbonate | SEVELAMER CARBONATE | Bionpharma Inc. | c3cf4807-ae5f-528e-e053-2a95a90ac640 | 2024-08-22 | Warnings, Adverse reactions | 9YCX42I8IU |
| Sevelamer Carbonate | SEVELAMER CARBONATE | TWi Pharmaceuticals, Inc. | 05b076d9-6516-4538-8e05-9709a677ed2f | 2024-08-21 | Warnings, Adverse reactions | 9YCX42I8IU |
| Sevelamer carbonate | SEVELAMER CARBONATE | Zydus Lifesciences Limited | cbdee883-ccc7-4c55-965d-b608a214b375 | 2024-08-12 | 9YCX42I8IU | |
| Sevelamer Carbonate | SEVELAMER CARBONATE | NCS HealthCare of KY, LLC dba Vangard Labs | ccfde4dd-b258-4baf-995b-a24bed8c84d7 | 2024-08-09 | Warnings, Adverse reactions | 9YCX42I8IU |
| Sevelamer Carbonate | SEVELAMER CARBONATE | American Health Packaging | bd0a89ab-91c4-42b3-aa88-1e3295d0d344 | 2024-07-30 | Warnings, Adverse reactions | 9YCX42I8IU |
| Sevelamer Carbonate | SEVELAMER CARBONATE | Proficient Rx LP | ee9da697-2d55-48e5-8e03-c64c8aaf1fb8 | 2024-05-01 | Warnings, Adverse reactions | 9YCX42I8IU |
| Sevelamer Carbonate | SEVELAMER CARBONATE | NorthStar Rx LLC | 9b4d0720-f4e7-4b4f-affc-57ce8bb0b722 | 2024-04-24 | Warnings, Adverse reactions | 9YCX42I8IU |
| Sevelamer Carbonate | SEVELAMER CARBONATE | Aurobindo Pharma Limited | ab0cd45f-0c4b-4ce7-bf8e-5f98d43feaab | 2024-04-04 | Warnings, Adverse reactions | 9YCX42I8IU |
| SEVELAMER CARBONATE | SEVELAMER CARBONATE | Aurobindo Pharma Limited | ea201bff-cdfb-4304-bdb1-d05c1dac2677 | 2023-12-08 | Warnings, Adverse reactions | 9YCX42I8IU |
| Sevelamer carbonate | SEVELAMER CARBONATE | Zydus Pharmaceuticals USA Inc. | 71f61492-8971-424a-8415-dfd2e15d05d9 | 2023-11-07 | Warnings, Adverse reactions | 9YCX42I8IU |
| Sevelamer Carbonate | SEVELAMER CARBONATE | Amneal Pharmaceuticals LLC | 94d8cfb1-ff2a-4956-8954-17635ac505d9 | 2023-11-05 | Warnings, Adverse reactions | 9YCX42I8IU |
| Sevelamer carbonate | SEVELAMER CARBONATE | Cipla USA Inc. | 134f32c1-b5d5-44d0-9da5-85033e99320a | 2023-01-18 | Warnings, Adverse reactions | 9YCX42I8IU |
| sevelamer carbonate | SEVELAMER CARBONATE | Amneal Pharmaceuticals of New York LLC | da5239fe-060b-4469-95ac-173adec43b9c | 2020-12-31 | Warnings, Adverse reactions | 9YCX42I8IU |
| Sevelamer carbonate | SEVELAMER CARBONATE | Exelan Pharmaceuticals Inc. | f8947f65-57be-4af7-b0e7-17666f496d01 | 2020-10-09 | Warnings, Adverse reactions | 9YCX42I8IU |
| Sevelamer Carbonate for Oral Suspension | SEVELAMER CARBONATE FOR ORAL SUSPENSION | Dr. Reddys Laboratories Inc | de172c3d-17eb-3489-35fb-370a0893b663 | 2020-05-20 | Warnings, Adverse reactions | 9YCX42I8IU |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.